The ulcerative colitis treatment landscape is undergoing remarkable transformation as pharmaceutical researchers develop increasingly targeted therapeutic modalities. Traditional medications such as aminosalicylates, corticosteroids, and immunomodulators maintain their importance as cornerstone therapies, yet the medical community is rapidly embracing personalized approaches that accommodate...